Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) Stock Ticker

NASDAQ: CRDL · Healthcare · Drug Manufacturers - Specialty & Generic
$1.71-1.16%
USD · as of 2026-09-28 · market cap $197.1M
Open CRDL in TickrRead the CRDL AI analysisDownload for iPhone

CRDL right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±15.3%
Options expect by Oct 29±31.7%
Priced in for Nov 12 earnings±38.3%
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full CRDL picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on CRDL
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. This pivotal trial assesses CardiolRx's safety and effectiveness as a cardioprotective treatment to diminish cardiovascular and respiratory complications in hospitalized COVID-19 patients, while also investigating its potential for acute myocarditis. Furthermore, the company is developing a subcutaneous version of CardiolRx, aimed at addressing the cardiac fibrosis and inflammation linked to the onset and progression of heart failure. Cardiol Therapeutics Inc. was established in 2017 and operates from its headquarters in Oakville, Canada.

CRDL stock facts

Ticker symbolCRDL
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$197.1M
CEODavid G. Elsley
Employees18
HeadquartersOakville, ON, CA
IPO date2019-01-15
Websitewww.cardiolrx.com

What you can see for CRDL on Tickr

Live CRDL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CRDL report.

Rankings

Largest Healthcare companiesLargest companies by market cap

CRDL peers

ASRTCNTBHYPRIFRXIMAINCRKLRSMBOT

FAQ

What is the ticker symbol for Cardiol Therapeutics Inc.?

The ticker symbol for Cardiol Therapeutics Inc. is CRDL, listed on the NASDAQ Capital Market.

What is CRDL?

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. This pivotal trial assesses CardiolRx's safety and effectiveness as a…

HomeExploreMarketLists
All pages